Does diabetes therapy influence the risk of cancer? U. SmithE. A. M. Gale Editorial 14 July 2009 Pages: 1699 - 1708
Exercise intensity and insulin sensitivity: how low can you go? J. A. HawleyM. J. Gibala Commentary 26 June 2009 Pages: 1709 - 1713
Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? K. FærchK. Borch-JohnsenA. Vaag Review 10 July 2009 Pages: 1714 - 1723
Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications N. IrwinP. R. Flatt Review 17 June 2009 Pages: 1724 - 1731
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study L. G. HemkensU. GrouvenP. T. Sawicki Article Open access 30 June 2009 Pages: 1732 - 1744
Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden J. M. JonassonR. LjungG. Steineck Article 09 July 2009 Pages: 1745 - 1754
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group H. M. ColhounSDRN Epidemiology Group Article Open access 15 July 2009 Pages: 1755 - 1765
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes C. J. CurrieC. D. PooleE. A. M. Gale Article 02 July 2009 Pages: 1766 - 1777
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study J. RosenstockV. FonsecaM. Davis Article Open access 13 June 2009 Pages: 1778 - 1788
Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients D. HansenP. DendaleL. J. C. van Loon Article Open access 16 April 2009 Pages: 1789 - 1797
Glucose challenge test screening for prediabetes and undiagnosed diabetes L. S. PhillipsD. C. ZiemerD. D. Koch Article 26 June 2009 Pages: 1798 - 1807
Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study D. G. BruceW. A. DavisT. M. E. Davis Article 03 July 2009 Pages: 1808 - 1815
Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes P. WiesliP. KrayenbühlC. Schmid Short Communication 30 June 2009 Pages: 1816 - 1819
Familial association between type 1 diabetes and other autoimmune and related diseases K. HemminkiX. LiK. Sundquist Article 20 June 2009 Pages: 1820 - 1828
Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients J. GrauslundA. GreenA. K. Sjølie Article 12 July 2009 Pages: 1829 - 1835
Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry A. IcksT. DickhausC. Meisinger Article 15 July 2009 Pages: 1836 - 1841
Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutrition-related diabetes? S. AlemuA. DessieE. H. O. Parry Short Communication 30 June 2009 Pages: 1842 - 1845
Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? L. SouthamN. SoranzoE. Zeggini Short Communication Open access 13 June 2009 Pages: 1846 - 1851
IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variants E. MoriniS. PrudenteV. Trischitta Article 26 June 2009 Pages: 1852 - 1857
A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis S. M. BlackmanS. HsuG. R. Cutting Article 08 July 2009 Pages: 1858 - 1865
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk E. ReilingE. van ’t RietL. M. ’t Hart Article Open access 17 June 2009 Pages: 1866 - 1870
JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis S. AbdelliJ. PuyalC. Bonny Article 16 July 2009 Pages: 1871 - 1880
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk P. AchenbachV. LampasonaA. G. Ziegler Article 10 July 2009 Pages: 1881 - 1888
Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism S. FujitaE. L. GlynnE. Volpi Article 09 July 2009 Pages: 1889 - 1898
Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2) S. RomeE. MeugnierH. Vidal Article 10 July 2009 Pages: 1899 - 1912
WNT/β-catenin increases the production of incretins by entero-endocrine cells J. M. García-MartínezA. Chocarro-CalvoC. García-Jiménez Article 07 July 2009 Pages: 1913 - 1924
Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus L. YeK. O. LeeE. K. W. Sim Article 12 July 2009 Pages: 1925 - 1934
Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies E. M. HorváthR. MagenheimZ. Lacza Article 14 July 2009 Pages: 1935 - 1943
Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1 R. LennonG. I. WelshM. A. Saleem Article 17 June 2009 Pages: 1944 - 1952
Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications J. WongS. V. McLennanD. K. Yue Article 21 July 2009 Pages: 1953 - 1961
Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP M. J. A. van der PlasM. BaldryP. H. Nibbering Article Open access 03 July 2009 Pages: 1962 - 1970
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study J. RosenstockV. FonsecaM. Davis Letter Open access 16 July 2009 Pages: 1971 - 1973